chr14-33929149-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022073.4(EGLN3):āc.541A>Gā(p.Ile181Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGLN3 | NM_022073.4 | c.541A>G | p.Ile181Val | missense_variant | 3/5 | ENST00000250457.9 | |
EGLN3 | NM_001308103.2 | c.259A>G | p.Ile87Val | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGLN3 | ENST00000250457.9 | c.541A>G | p.Ile181Val | missense_variant | 3/5 | 1 | NM_022073.4 | P1 | |
EGLN3 | ENST00000553215.5 | c.259A>G | p.Ile87Val | missense_variant | 3/5 | 1 | |||
EGLN3 | ENST00000487915.6 | c.187A>G | p.Ile63Val | missense_variant | 6/6 | 5 | |||
EGLN3 | ENST00000556785.1 | n.305A>G | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251430Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135880
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461878Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.541A>G (p.I181V) alteration is located in exon 3 (coding exon 3) of the EGLN3 gene. This alteration results from a A to G substitution at nucleotide position 541, causing the isoleucine (I) at amino acid position 181 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at